Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01486667

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01486667
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Saudi Arabia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01486667. Randomized; quadruple masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2013-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP
Condition
Dyslipidemia
Intervention (Drug)
levothyroxine
Intervention (Drug)
sugar pill
Lead sponsor
King Saud University (class: other)

Record details

Record id
cardio:ct-nct01486667
Content hash
5edb3eee961837b9b56e6d7a2a19cfc2ddbf0399f9a7749a9e514a725cb41736